Rhabdomyosarcoma - Pipeline Review, H1 2012 New Report
Rhabdomyosarcoma - Pipeline Review, H1 2012, provides an overview of the Rhabdomyosarcoma therapeutic pipeline. This report provides information on the therapeutic development for Rhabdomyosarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Rhabdomyosarcoma. 'Rhabdomyosarcoma - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites...
View full press release